Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2007-11-01Clinical Trial Update: Right Ventricular Defibrillation Lead Select Site Study [NA]
A clinical trial update for the Right Ventricular Defibrillation Lead Select Site Study, sponsored by Associates in Cardiology, PA, is provi…
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure [Phase 4]
A Phase 4 study evaluated the effect of irbesartan on insulin sensitivity in patients with chronic heart failure; the trial status is comple…
-
FDA approval · 2007-10-30FDA Approved: DIGOXIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Digoxin under an original ANDA, allowing generic Digoxin from Hikma Pharmaceuticals USA Inc. to be marketed.
-
FDA approval · 2007-10-25FDA Approved: CARVEDILOL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for carvedilol from Quallent Pharmaceuticals Health LLC to market a generic version of the drug.
-
CLINICAL_TRIALS withdrawal · 2007-10-25Clinical Trial Update: Metabolic Modulation as Treatment in Acute Heart Failure [Phase 2]
Phase 2 clinical trial evaluating metabolic modulation as a treatment for acute heart failure was terminated. No results are reported.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-10-23FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Quinapril submitted by BluePoint Laboratories. This approval updates the existing Quinapril …
-
FDA approval · 2007-10-19FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2007-10-19FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for carvedilol submitted by Aurobindo Pharma Limited for a generic product.
-
FDA approval · 2007-10-19FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for carvedilol filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2007-10-17FDA Approved: TORSEMIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original Abbreviated New Drug Application for torsemide from Rising Pharma Holdings, granting regulatory clearance for a ge…
-
FDA approval · 2007-10-16FDA Approved: CARVEDILOL — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for a generic carvedilol product (ANDA 078165). This approval expands the availab…
-
CLINICAL_TRIALS trial_result · 2007-10-15Clinical Trial Update: Effect of Beta Blocker Treatment on Endothelial Function in Patients With Type 2 Diabetes or Chronic Heart Failure [Phase 4]
A Phase 4 clinical trial evaluated the effect of beta-blocker treatment on endothelial function in patients with type 2 diabetes mellitus or…
-
CLINICAL_TRIALS research · 2007-10-15Clinical Trial Update: MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial) [Phase 1]
Phase 1 trial update for MYOHEART, Bioheart’s investigational therapy for heart disease; the trial status is currently unknown.
-
CLINICAL_TRIALS research · 2007-10-12Clinical Trial Update: Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial [Phase 2]
Phase 2 trial update examining the safety and effects of implanted autologous skeletal myoblasts (MyoCell) delivered via an injection cathet…
-
CLINICAL_TRIALS trial_result · 2007-10-05Clinical Trial Update: InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy
The InSync Implantable Cardioverter Defibrillator Registry study evaluating Cardiac Resynchronization Therapy in heart failure and cardiomyo…
-
FDA approval · 2007-10-03FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Torsemide from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2007-10-02Clinical Trial Update: Effect of Folic Acid on Endothelial and Baroreceptor Function in Patients With Heart Failure [Phase 4]
Phase 4 trial evaluating folic acid's effect on endothelial and baroreceptor function in patients with heart failure was terminated.
-
CLINICAL_TRIALS trial_result · 2007-09-24Clinical Trial Update: Utility of Serial BNP Levels in Emergency Department CHF
A completed clinical trial assessing whether serial BNP measurements in the emergency department improve assessment or management of congest…
-
CLINICAL_TRIALS trial_result · 2007-09-24Clinical Trial Update: Biventricular Pacing After Coronary Artery Bypass Grafting (BIVAC) [NA]
The BIVAC trial evaluating biventricular pacing after coronary artery bypass grafting has completed.
-
CLINICAL_TRIALS research · 2007-09-20Clinical Trial Update: N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure [Phase 2, Phase 3]
Clinical trial update describing Phase 2/Phase 3 evaluation of N-acetylcysteine in patients with heart failure and coexisting chronic kidney…
-
FDA approval · 2007-09-19FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved hydrochlorothiazide from Aurobindo Pharma Limited under an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2007-09-10Clinical Trial Update: Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure [Phase 4]
Phase 4 study evaluating the renal effects of levosimendan in patients with acute decompensated heart failure; current status is not disclos…
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original application for carvedilol (generic) from Glenmark, enabling generic access to carvedilol for the indicated condit…
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Carvedilol on an original application by Dr. Reddy's Laboratories Limited (generic carvedilol).
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Advagen Pharma Ltd)
FDA approved the original application for Carvedilol from Advagen Pharma Ltd, a generic version of carvedilol. The drug is indicated for hyp…